Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese mice-Reference-Cited by-同舟云学术

Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese mice

Published:2018 Issue:54 Volume:8 Page:31194-31200
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Mo Juan-Fen¹²³⁴^ORCID,Wu Jia-Yuan¹²³⁴,Zheng Li¹²³⁴,Yu Ya-Wei⁵²³⁴,Zhang Tian-Xin⁶²³⁴,Guo Li¹²³⁴,Bao Yi¹²³⁴

Affiliation:

1. The Key Laboratory

2. The Second Affiliated Hospital of Jiaxing University

3. Jiaxing

4. China

5. Department of Pathology

6. Clinical Laboratory

Abstract

Polydatin (PD), a natural precursor of resveratrol, has been used to treat several diseases, such as cardiovascular diseases, hepatic diseases and various cancers.

Funder

Natural Science Foundation of Zhejiang Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/RA/C8RA05915B

Reference38 articles.

1. Polydatin: A review of pharmacology and pharmacokinetics

2. Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury

3. Polydatin attenuatesd-galactose-induced liver and brain damage through its anti-oxidative, anti-inflammatory and anti-apoptotic effects in mice

4. Root Extract of Polygonum cuspidatum Siebold & Zucc. Ameliorates DSS-Induced Ulcerative Colitis by Affecting NF-kappaB Signaling Pathway in a Mouse Model via Synergistic Effects of Polydatin, Resveratrol, and Emodin

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Mix of Polyphenols and Micronutrients Reduces Adipogenesis and Promotes White Adipose Tissue Browning via UCP1 Expression and AMPK Activation;Cells;2023-02-24

2. Polydatin: A Critical Promising Natural Agent for Liver Protection via Antioxidative Stress;Oxidative Medicine and Cellular Longevity;2022-02-10

3. Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease;Pharmacological Research;2021-04

4. Polydatin prevents bleomycin‑induced pulmonary fibrosis by inhibiting the TGF‑β/Smad/ERK signaling pathway;Experimental and Therapeutic Medicine;2020-09-04

5. Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis;Life Sciences;2020-08